Sepragen (SPGNA) Signs Supply Agreement With Pall Corporation (PLL) For Bench-Top Chromatography Systems
10/19/2005 5:12:47 PM
HAYWARD, Calif.--(BUSINESS WIRE)--Feb. 22, 2005--Sepragen Corporation (Pink Sheets:SPGNA), a provider of patented technology and equipment for purification needs in the biotech and nutraceutical industries, today announced that it has signed a multi-year agreement with filtration and purification industry leader, Pall Corporation (NYSE:PLL). Under the agreement, Sepragen will develop and manufacture bench top process development chromatography systems for Pall. The products, which augment Pall's extensive capabilities, will be sold and supported by Pall's global sales and technical support network.
Ken Frank, President of Pall BioPharmaceuticals said, "We are very pleased with our new alliance with Sepragen, which has a track record of developing innovative products for chromatography. The addition of these small-scale systems to our chromatography line expands our ability to satisfy customers' increasing needs for purification systems that span the drug development and production process." Products that scale up easily from the lab to the manufacturing floor are one key to the industry's ability to bring new drugs to market quickly.
comments powered by